General Information of the Compound
Compound ID |
CP0532116
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(E)-1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-8,9-dihydro-7H-pyrimido[5,4-h][1,5]benzoxazepin-6-yl]-4-pyrrolidin-1-ylbut-2-en-1-one
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C32H31ClFN5O3
|
||||||||||||||||||
Molecular Weight |
588.083
|
||||||||||||||||||
Canonical SMILES |
Fc1cccc(COc2ccc(Nc3ncnc4cc5OCCCN(C(=O)\C=C\CN6CCCC6)c5cc34)cc2Cl)c1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C32H31ClFN5O3/c33-26-17-24(9-10-29(26)42-20-22-6-3-7-23(34)16-22)37-32-25-18-28-30(19-27(25)35-21-36-32)41-15-5-14-39(28)31(40)8-4-13-38-11-1-2-12-38/h3-4,6-10,16-19,21H,1-2,5,11-15,20H2,(H,35,36,37)/b8-4+
Show/Hide
|
||||||||||||||||||
InChIKey |
UNBUUPBBTITRER-XBXARRHUSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound